RegisterLogin

BAY-593

CAT: 0804-HY-161573-01Size: 5 mgDry Ice: NoHazardous: No
CAT#: HY-161573-01Size: 5 mg
Selected
PRICE
AVAILABILITY
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
BAY-593 is an orally active GGTase-I inhibitor. BAY-593 can block YAP1/TAZ signaling in animals and has antitumor activity[1].
CAS Number
[2413020-56-9]
UNSPSC
12352005
Target
GGTase; YAP
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Stem Cell/Wnt
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bay-593.html
Purity
99.94
Solubility
DMSO : 116.67 mg/mL (ultrasonic)
Smiles
O=C(N1CCC2(CCNC[C@@]2([H])C3=CC=CC=C3OC)CC1)[C@@](OC)(C(F)(F)F)C4=CC=CC=C4
Molecular Formula
C26H31F3N2O3
Molecular Weight
476.53
References & Citations
[1]Graham K, et al. Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling. Cell Chem Biol. 2024 Mar 19:S2451-9456 (24) 00087-4.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
GGTase I

Related Products

CatalogName
HY-15506-01TAK-593
HY-W952924CRBN ligand-593
HY-160922-01BAY 249716
HY-132293-01BAY-8400
HY-152106A-01(+) -BAY-7081
HY-152106B-01(±) -BAY-7081
HY-156701BAY-1128688
HY-150239BAY-364
HY-162284-01BAY-9835
HY-103020-01BAY-1816032

Alternative Products

CatalogName
T201377-01BAY 593
T85805-01BAY-593
C01993-01BAY-593
BUP23859-01BAY-593
T89195-01(7S) -BAY-593
M23210-01TAK-593
B3268-5TAK-593
MBS5755578TAK-593
MBS3612897-01TAK-593
T16975-01TAK-593

Popular Products